The combined stack: PrismSpy plus Meta Catalyst IQ as one Meta ads operating system for Indian healthcare in 2026

Most Indian healthcare brands running Meta ads think of the problem as an execution problem. Hire a good media buyer, brief them on the funnel, watch the CPL, tweak the creative. That framing is why 30 to 50 percent of Meta ad budgets in Indian healthcare quietly become waste each month. The problem is not execution in isolation. The problem is that execution without intelligence is bidding blind, and intelligence without execution is a report nobody acts on. This post lays out how ICG runs the two together as one operating system: PrismSpy as the daily competitive intelligence layer, and Meta Catalyst IQ as the daily decision plus execution layer. Together they compress what most agencies split into two rhythms — the quarterly competitor deck and the daily media-buyer report — into one closed loop that reduces spend waste from portfolio-typical 30-50 percent down to 5-12 percent within a 90-day window.

The half-stack problem — why single-layer Meta ads programmes plateau

Almost every healthcare brand we audit runs half a stack. The intelligence half or the execution half, rarely both, and never linked. The intelligence half looks like a quarterly competitor deck built by a strategist who spent a week clicking through Meta Ad Library and interviewing the sales team. It reads well, it gets circulated, and then it becomes irrelevant six weeks later when a competitor launches a new offer nobody is watching for. The execution half looks like a media buyer running weekly reports on CPL, CTR, and hook rate, adjusting bids and killing under-performers, but with no view of what the competitors that share their audience are running that week.

The failure mode is subtle. The media buyer optimises against a static target — historical CPL — while the competitive landscape moves underneath them. When a competitor launches a new offer that resets audience expectations, the buyer sees CPL rising and blames creative fatigue. They refresh the creative. CPL keeps rising, because the problem was never their creative — it was that the market moved and they did not know. The strategist, meanwhile, is halfway through building the next quarterly deck and will not surface the shift until it is 8 to 10 weeks old.

The half-stack problem is not fixed by hiring better people. It is fixed by collapsing intelligence and execution into a single daily rhythm. That is what the combined stack does.

Two layers, one operating system — the mental model

The mental model that makes the combined stack legible is simple. Think of Meta ads as a two-layer problem: what to run against, and how to run it profitably. PrismSpy answers the first. Meta Catalyst IQ answers the second. Neither answer is complete without the other.

PrismSpy tracks 75+ Indian healthcare brands across 30+ specialties, 2,150+ active ads catalogued, ₹50Cr+ of aggregate competitor ad spend visibility every month, and 1,197 offers indexed with discount intensity by brand. What that gives you is a live view of the competitive market — top spenders in your specialty, dominant hooks, longest-running creatives (proven converters), emerging offers, killed ads (things that stopped working), and the format mix that is currently over- or under-indexed in the category.

Meta Catalyst IQ runs the diagnosis and decision layer on top of your own account. Hygiene Factors (a 12-point operational checklist), Naming Intelligence that surfaces naming conflicts costing accounts ₹50K-₹2L a month in avoidable misattribution, Creative Scoring Matrix that groups every ad into Core Performer, Scalable, Getting Started or Review, 2-Day Comparative and Long-term Comparison, Money Wastage column expressed in rupees, and the CPQL (cost per qualified lead) engine that scores CPL by qualification not raw volume. Currently running across 23+ healthcare accounts optimising ₹9.1Cr+ per month, delivering ₹1,581 blended CPL versus a market benchmark of around ₹3,200.

The combined stack is not two dashboards you check separately. It is one operating rhythm where the outputs of one feed the inputs of the other, every day.

The two-tool loop: intel → execution → intel

The reason single-tool Meta ads programmes plateau is that intelligence and execution live in separate rhythms. Weekly competitor scan by a strategist. Daily campaign management by a media buyer. They never fully close the loop. PrismSpy + Meta Catalyst IQ compress that into one daily rhythm inside ICG:

1. Morning (PrismSpy) — scan overnight changes across the specialty watchlist. New offers, killed ads, spend spikes.
2. Midday (Meta Catalyst IQ) — 2-Day Comparative + Money Wastage review. What in our own account moved, and why?
3. Afternoon (loop) — creative brief for tomorrow's ads uses PrismSpy's Inspirations swipe file (what's working in-category) plus Catalyst's Creative Scoring (what's working for us specifically).

The output isn't more reports. It's fewer wasted rupees. ICG portfolio average: 30–50% of pre-optimisation Meta spend was waste; post-optimisation it drops to 5–12%.

What the morning PrismSpy scan actually looks like

The morning scan takes ten to fifteen minutes per specialty cluster. The pattern is the same across IVF, dermatology, dental, aesthetic, hair transplant, and hospital multi-specialty. Open the Watchlist Dashboard for the cluster. Read the Activity Feed for the last 24 hours in reverse chronological order. Every event is tagged — Spend, Strategy, Launches, Pauses, Offers. What you are looking for is not novelty for its own sake but signal. A competitor whose spend rose 43 percent overnight is telling you something. A competitor who launched five new ads and paused eight is telling you something. A brand that added a "free assessment plus WhatsApp booking" offer that did not exist yesterday is telling you something.

angryturtle/01-listing-overview.png" alt="Angryturtle Listing Overview — GBP watchlist with per-listing status, category, sub-scores, action count for 143+ managed Indian healthcare listings" loading="lazy" decoding="async" style="width:100%;height:auto;display:block;">

The second read is Comparative Insights — Longest Run Creatives (ads that have been active 200+ days are almost always proven converters), Highest Quality ads by scoring, Most Common Hooks (the language patterns dominating the category this week), and Emerging Offers (new bundle structures appearing across two or more competitors within the same seven-day window). Emerging Offers is the most valuable single view because it tells you where the category is drifting before your own CPL feels it.

The third read, done twice weekly rather than daily, is Offers Intelligence and Service Cluster. Offers Intelligence shows discount intensity by brand across all 1,197 catalogued offers. Service Cluster shows which of the 419 tracked services are heating up and which are cooling. The two reads together give you a market map with roughly a two-week lead time before those shifts show up in your own account's cost curves.

What the midday Meta Catalyst IQ review actually covers

The midday review is where the intelligence from PrismSpy gets tested against the reality of your own account. Open the Master Dashboard for the day. Read the 2-Day Comparative — every ad set tracked across four KPIs, colour-coded green for improved and red for worsened, with critical flags, scaling flags, and opportunity flags surfaced automatically. This is a three-minute read for a healthy account and a ten-minute read for an account with issues.

Next, drill into any ad set that flipped red overnight. The three questions are the same every time. Is this a hygiene problem (a naming conflict, a broken CAPI event, a saturated audience)? Is this a creative problem (hook rate dropping, hold rate collapsing, CTR down)? Or is this a market problem (competitors spending more or running a better offer)? The first two questions get answered inside Meta Catalyst IQ. The third question sends you back to the morning's PrismSpy scan.

Once diagnosis is done, the Action Centre proposes decisions. "Kill these eight ads (CPM up 65%, hold rate dropped 50%)." "Scale these three ad sets (CPL down 30%, hook rate up 28%)." "Rename these six ad sets (naming conflict against Lead Source rollup)." The Action Centre does not act on its own — a human media buyer executes. What Meta Catalyst IQ does is remove the guesswork about what to act on and why.

The Money Wastage column runs alongside all of this. Every ad in the account carries a rupee-denominated waste estimate — the spend that would have gone to a better-performing sibling ad if the sibling had received the delivery. Weekly Money Wastage Cleanup surfaces the top ten wasted ads with recommended action. This is the single most actionable metric in the platform because it converts abstract inefficiency into a rupee number the account owner cares about.

How the afternoon creative brief closes the loop

The afternoon is where the loop actually closes. The creative brief for tomorrow's ads is written using two inputs. The first is PrismSpy's Inspirations swipe file — 4,697 catalogued ads searchable by hook, language, format, problem targeted, and benefit highlighted. This is not a copy-cat exercise. It is a systematic survey of what the specialty has already tested. When you can see that eleven competitors in your IVF cluster are running variants of a "first consultation free" hook and only three are running a "success rate substantiation" hook, that shapes your creative decision.

The second input is Meta Catalyst IQ's Creative Scoring Matrix. Your own Core Performer ads — the ones scoring highest on hook rate, hold rate, CTR, CPL, and result rate — get analysed for common structural patterns. What length are they? What opening frame? What CTA framing? What music tempo? The pattern that emerges from your own top quartile ads is your account's creative signature. The next brief either amplifies that signature or explicitly departs from it with a stated hypothesis.

The brief itself is short — one page, hook line, opening frame, structural approach, CTA framing, targeting hypothesis, and one line stating why this brief is being written now (either "market drift observed via PrismSpy" or "internal creative fatigue observed via Catalyst"). The one-page brief is the tangible artefact that proves the loop actually closed. Without that artefact, most Meta ad programmes settle back into either weekly-report cadence or gut-feel briefing within four to six weeks.

The 90-day transition from half-stack to full-stack

Moving from a single-layer programme to the combined stack is a 90-day transition, not an overnight switch. Weeks one through three are foundation work. The Hygiene Factors 12-point checklist gets run on the account. Every failed check gets scheduled for fix. Naming Intelligence surfaces the naming conflicts and the account moves to a consistent SLC (Service, Location, Format, Content, Details) naming schema. Beacon (ICG's Meta CAPI attribution engine) gets installed to recover the 30 to 50 percent of attribution signal that iOS14 and third-party cookie deprecation cost most accounts. PrismSpy's watchlist for the specialty is calibrated — the default 30 to 75 competitor list gets pruned or extended to reflect the actual competitive set the brand faces in its city or region.

Weeks four through eight are the diagnostic phase. The daily two-tool loop starts. Creative Scoring Matrix begins producing meaningful zone classifications after 10 to 14 days of data. Audience Size vs Efficiency verdicts start stabilising around week three. Money Wastage Cleanup starts producing rupee-denominated savings from month one. The first PrismSpy-driven creative brief goes out in week five, roughly two weeks after the analyst has enough Activity Feed history to recognise pattern versus noise.

Weeks nine through twelve are the compounding phase. The CPQL engine has enough qualified-lead history to score at ad-set level. Portfolio CPL benchmarks — the blended ₹1,581 across ICG's 23+ accounts, or the specialty-specific IVF ₹632, derm ₹520-1,180, dental ₹620-1,800, aesthetic ₹400-900, hospital cardiac ₹3,200 — become achievable targets rather than aspirational ones. The 38 to 58 percent CPL reduction benchmark is realistic for accounts that completed weeks one through eight without cutting corners.

What the combined stack does not do

Honest boundaries matter more than exaggerated claims. The combined stack does not replace Meta Ads Manager — you still publish through Meta's own tools. It does not replace a media buyer — a human still executes the decisions. It does not automate bidding — tools like Madgicx or Smartly automate bidding, and the combined stack sits above them or alongside them. It does not fabricate demand — if your specialty has structural demand issues in your city, no ad-stack will manufacture patients that do not exist.

It also does not deliver results in week two. Every claim in this post is anchored to a 90-day timeline because the underlying mechanics — creative scoring stabilising, Meta's Learning Phase completing, portfolio-level pattern emerging — take that long. Any Meta ads vendor promising faster is either fabricating numbers or optimising a single metric at the expense of others.

Finally, it does not remove the compliance perimeter. NMC Ethics Code 2026, ASCI Guidelines 2022, DPDP Act 2023, and specialty-specific rules like the ART Act 2021 for IVF or PC-PNDT Act 1994 for prenatal remain the framing constraint on what any Meta ad can say. The stack helps here by making violations visible earlier (PrismSpy surfaces competitor claims that look non-compliant so the client can benchmark their own conservatism against actual market practice) — but the compliance judgement remains a human call.

How the combined stack changes what you report to leadership

The most under-appreciated effect of the combined stack is what it changes about internal reporting. Most Meta ads programmes report CPL, CTR, spend, and leads to the CMO or the founder. Those numbers are lagging. They tell you what happened; they do not tell you what to do next.

The combined stack changes the report. The weekly report becomes: (1) what changed in the competitive landscape this week (from PrismSpy); (2) what changed in our account performance this week (from Catalyst 2-Day Comparative); (3) how those two are connected (the interpretive layer); (4) what we decided to do about it (the Action Centre outputs the media buyer executed); (5) rupee-denominated savings from Money Wastage Cleanup this week; (6) portfolio CPL trajectory against benchmark.

That report reads differently to leadership. It reads like an operating system running under conscious management, not a black box producing numbers of unclear provenance. CFOs specifically respond to Money Wastage in rupees because it is the only Meta ads metric that maps cleanly to how they think about the P&L.

Powered by PrismSpy — every competitor Meta ad, watched daily

ICG built PrismSpy because Indian healthcare Meta ad competition is invisible without it. 75+ Indian healthcare brands tracked, 2,150+ active ads catalogued, ₹50Cr+ aggregate ad spend visibility per month. Every competitor ad — creative, offer, hook, run-length — refreshed daily. It runs underneath every Meta ads and performance marketing engagement at ICG.

• Watchlist Dashboard — 30–75 competitors per specialty cluster (IVF / dermatology / dental / hair transplant / aesthetic / hospital), daily refresh.
• Comparative Insights — highest-quality ads, longest-running creatives (proven converters), top hooks, emerging offers.
• Offers Intelligence — 1,197 offers tracked, discount intensity by brand, value tier distribution.
• Service Cluster + Inspirations — 419 services tracked, 4,697 searchable ad inspirations by hook / language / format.

Standalone from ₹4,999/- per specialty vertical, or bundled free inside HealthApex OS (₹14,999/- flat, 9 tools). Book a 30-min PrismSpy walkthrough on WhatsApp — Rohit + Hanuman walk you through your specialty's competitive landscape.

Powered by Meta Catalyst IQ — the decision engine behind every Meta ad ICG runs

ICG built Meta Catalyst IQ because most Indian healthcare brands running Meta ads waste 30–50% of budget without knowing it. It's the diagnosis + decision layer above Ads Manager — Hygiene Factors 12-point checklist, Naming Intelligence (surfaces conflicts costing ₹50K–₹2L/account/month), Creative Scoring Matrix (Core Performer / Scalable / Getting Started / Review), 2-Day Comparative, SLC Framework, Money Wastage column in ₹.

• Master Dashboard — 23+ accounts, ₹9.1Cr+ spend/mo optimised, ₹1,581 blended CPL vs ~₹3,200 market benchmark.
• Diagnose → Optimise → Grow — daily hygiene checks, weekly creative scoring, monthly money wastage cleanup.
• CPQL Engine — cost per qualified lead (not just cost per lead) at ad-set level. Try the interactive CPQL calculator.
• Portfolio benchmarks — IVF ₹632, derm ₹520–1,180, dental ₹620–1,800, aesthetic ₹400–900, hospital cardiac ₹3,200.

Included free with every ICG Meta ads or Performance Marketing engagement (Starter ₹20,000/-/month tier and above). Not sold standalone. Book a free 48-hour Meta ad diagnostic or WhatsApp us.

FAQ

How much does the combined stack cost end to end?

PrismSpy is ₹4,999/- per specialty vertical standalone or free inside HealthApex OS (₹14,999/- flat, 9 tools). Meta Catalyst IQ is not sold standalone — it is included free with every ICG Meta ads engagement from the Starter tier at ₹20,000/- per month upward. A healthcare brand running Meta ads with ICG effectively gets Meta Catalyst IQ bundled and adds PrismSpy for either ₹4,999 or ₹14,999 depending on whether they want the single specialty or the full HealthApex OS.

Can we run just PrismSpy without engaging ICG for Meta ads execution?

Yes. PrismSpy is standalone-available and many brands use it as their competitive intelligence layer while their existing team or agency runs execution. Meta Catalyst IQ is not standalone. The combined stack economics work best when both layers are in the same operational loop, but a brand that has strong Meta ad execution already can still get material value from PrismSpy alone.

How is this different from just checking Meta Ad Library manually?

Meta Ad Library shows raw ads with no analysis, no scoring, no historical trend, no cross-competitor comparison, no offer indexing, no format-mix analysis. Doing what PrismSpy does manually across 30 to 75 competitors, daily, would take a full-time analyst per specialty cluster — that is what most agencies cannot justify and most brands have never had access to.

What if we already use Madgicx or Smartly for Meta ads automation?

The combined stack sits above those tools rather than replacing them. Madgicx and Smartly automate bidding and creative testing. Meta Catalyst IQ diagnoses which decisions to make and PrismSpy provides the market context those decisions are made in. A common ICG setup is Meta Catalyst IQ diagnosing, Madgicx or Smartly executing the operational bidding decisions, and a human buyer executing the creative and offer decisions. The three work together.

What is the fastest realistic CPL improvement you have seen?

Portfolio benchmark is 38 to 58 percent CPL reduction inside 90 days. Faster is possible when the starting hygiene state is particularly poor (unfixed naming conflicts, broken CAPI, saturated audiences all being fixed simultaneously), but promising faster is not honest. The compounding phase begins around day 60.

Does the stack cover Google ads too, or only Meta?

PrismSpy covers both Meta ads and Google Ads Transparency Centre data. Meta Catalyst IQ is Meta-specific. For Google Ads-side decisioning, ICG uses a separate diagnostic stack. The combined stack framing in this post is Meta-specific because Meta is where the largest healthcare ad-spend waste tends to concentrate.

What if our brand is smaller and only spends ₹2-3 lakh a month on Meta?

The combined stack still works but with different priorities. At smaller spend, Money Wastage Cleanup and Hygiene Factors deliver the biggest immediate returns because the smaller the account, the higher the percentage of budget waste tends to be. PrismSpy is equally valuable regardless of spend because it maps the competitive market rather than sizing decisions to your own budget.

Related reading

• Combined stack for IVF clinics — competitor intel plus Meta execution
• Combined stack for dermatology clinics
• Combined stack for multi-specialty hospitals
• Combined stack for dental clinics
• The Meta ads decision engine for Indian healthcare
• IVF clinic CPL reduction case study

Reference frameworks — Meta's own Meta Business help centre for Ads Manager, and India's Advertising Standards Council of India for compliance framing on healthcare advertising claims.